Ambev (NYSE:ABEV) Reaches New 1-Year Low at $2.35

Ambev S.A. (NYSE:ABEV - Get Free Report) shares reached a new 52-week low during trading on Friday . The stock traded as low as $2.35 and last traded at $2.36, with a volume of 1692912 shares traded. The stock had previously closed at $2.40.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on ABEV shares. StockNews.com started coverage on shares of Ambev in a research note on Friday, January 26th. They issued a "buy" rating for the company. JPMorgan Chase & Co. reissued a "neutral" rating on shares of Ambev in a research note on Friday, March 1st. Finally, Barclays downgraded shares of Ambev from an "overweight" rating to an "equal weight" rating and decreased their price objective for the stock from $3.50 to $3.00 in a research note on Monday, March 4th. Four research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $3.20.

Check Out Our Latest Analysis on Ambev

Ambev Stock Down 2.1 %

The company has a market cap of $37.01 billion, a P/E ratio of 13.06, a P/E/G ratio of 2.41 and a beta of 1.08. The company has a quick ratio of 0.66, a current ratio of 0.89 and a debt-to-equity ratio of 0.03. The business's 50 day moving average is $2.52 and its 200 day moving average is $2.64.


Ambev (NYSE:ABEV - Get Free Report) last issued its quarterly earnings data on Thursday, February 29th. The company reported $0.06 EPS for the quarter, topping analysts' consensus estimates of $0.05 by $0.01. Ambev had a net margin of 18.19% and a return on equity of 17.60%. The company had revenue of $4.04 billion during the quarter. As a group, equities analysts anticipate that Ambev S.A. will post 0.19 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Ambev

Several institutional investors and hedge funds have recently bought and sold shares of ABEV. Raymond James & Associates grew its holdings in Ambev by 37.0% in the first quarter. Raymond James & Associates now owns 1,039,250 shares of the company's stock worth $3,357,000 after purchasing an additional 280,753 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in shares of Ambev by 7.5% during the first quarter. Bank of New York Mellon Corp now owns 3,788,023 shares of the company's stock valued at $12,235,000 after buying an additional 264,696 shares during the last quarter. American Century Companies Inc. grew its holdings in shares of Ambev by 38.7% during the first quarter. American Century Companies Inc. now owns 503,973 shares of the company's stock valued at $1,628,000 after buying an additional 140,617 shares during the last quarter. Cambridge Investment Research Advisors Inc. grew its holdings in shares of Ambev by 35.3% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 35,172 shares of the company's stock valued at $114,000 after buying an additional 9,168 shares during the last quarter. Finally, HighTower Advisors LLC grew its holdings in shares of Ambev by 3.9% during the first quarter. HighTower Advisors LLC now owns 131,259 shares of the company's stock valued at $424,000 after buying an additional 4,984 shares during the last quarter. 8.13% of the stock is owned by hedge funds and other institutional investors.

Ambev Company Profile

(Get Free Report)

Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, other non-alcoholic beverages, malt, and food products. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe and Hoegaarden, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.

See Also

Should you invest $1,000 in Ambev right now?

Before you consider Ambev, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambev wasn't on the list.

While Ambev currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: